2022 年 12 月 8 日 Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
2022 年 11 月 7 日 Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
2022 年 10 月 19 日 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions